Trial Details
COMPLETEDBasic Information
| Clinical ID | c4558 |
|---|---|
| Identifier | NCT00329420 |
| Trial Title | Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab pegol|BIOLOGICAL: Certolizumab pegol|BIOLOGICAL: Certolizumab pegol |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Aichi-ken |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-05 |
|---|---|
| Primary Completion Date | 2008-05 |
| Completion Date | 2008-05 |